Furthermore, microRNA (miR-545-3p) can target PPA1 to inhibit cell proliferation and invasion and enhance cisplatin resistance by increasing JNK phosphorylation in ovarian cancer (39) (Table 1). Here, PPA1 is linked to ovarian carcinoma.